Skip to content
Screener

Prime Medicine PRME Business Segments — Operating Expenses

Similar metrics at other companies

Guidewire Software logo
GWREReportable Segment — Operating Expenses
$206.01M+15.6%
BitGo Holdings logo
BTGOReportable Segment — Operating Expenses
$3.79B+114%
Vaxcyte, Inc. logo
PCVXReportable Segment — Operating Expenses
$345.85M+91.3%
Forgent Power Solutions logo
FPSReportable Segment — Operating Expenses
$91.86M+101%
Andersen Group logo
ANDGReportable Segment — Operating Expenses
$216.67M+39.4%
SLM logo
SLMReportable Segment — Operating Expenses
$170.36M+10.9%

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Operating income-$43.3M+18.9%
Net income-$42.1M+19.9%
EPS (diluted)-$0.24+41.5%

Balance sheet

See full
Cash & equivalents$61.1M-9.4%
Total debt$112.5M-6.1%
Total equity$39.8M-34.6%
Total assets$249.0M-10.7%

Cash flow

See full
Operating cash flow-$41.0M+0.9%
CapEx$46.0K-97.1%
Free cash flow-$41.1M+4.4%

Valuation

See full
Market cap$558.64M-10.7%
Enterprise value$609.98M-10.0%

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-373.3%-1,281pp
Debt / equity2.8×+0.9×
Current ratio3.1×-0.5×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:03 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053883
(in thousands)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Facility related10,57713,76520,84324,734
Research costs6,1588,11613,41819,152
General and administrative expenses:
Personnel expenses5,5597,08211,09114,238
Other segment items (1)11,34511,08128,74420,966
Total operating expenses44,43954,49295,949108,338
Total other income, net1,1767862,7081,288
Net loss$(42,109)$(52,591)$(91,231)$(104,481)

Item 1. Financial Statements (unaudited)

FAQ

What is Prime Medicine's business segments — operating expenses?
Prime Medicine (PRME) reported business segments — operating expenses of $44.44M in Q2 2026.
How has Prime Medicine's business segments — operating expenses changed year-over-year?
Prime Medicine's business segments — operating expenses decreased by 18.4% year-over-year, from $54.49M to $44.44M.
What is the long-term trend for Prime Medicine's business segments — operating expenses?
Over 2 years (2023 to 2025), Prime Medicine's business segments — operating expenses has grown at a 2.0% compound annual growth rate (CAGR), from $204.79M to $212.98M.
What does business segments — operating expenses mean?
The aggregate of all costs incurred to operate a specific business segment, including personnel, facilities, research, and other administrative expenses. This metric provides a comprehensive view of the segment's total burn rate or operational cost burden. It is essential for evaluating the segment's cost management and operational efficiency.

Ask your AI about Prime Medicine's business segments — operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude